| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.3 | 7e-20 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.41 | 6e-16 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.37 | 6e-12 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.28 | 2e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |